The pulse oximeter maker is now fully operational after a spring cyberattack and increased its 2025 profit forecast, but ...

Medical technology company Masimo has been facing off with Apple in court since 2020, and while Masimo has scored some wins, ...

Medical tech company Masimo (NASDAQ:MASI) reported Q2 CY2025 results , with sales up 7.9% year on year to $370.9 million. The ...

Masimo Corp (MASI) reports robust earnings growth and outlines strategic advancements in healthcare technology amidst tariff ...

Fintech firm Fintiv accuses Apple of misconduct. The lawsuit echoes the Masimo case, which led to an import ban on certain Apple Watch models.

Q2 2025 Management View CEO Catherine M. Szyman reported "our core Healthcare business delivered strong growth and earnings performance. Revenue was $370 million, and we achieved earnings per share ...

Masimo (Nasdaq: MASI) shares dipped after hours today on second-quarter results that came in ahead of the consensus forecast.

Second Quarter 2025 Results Key Financial Results Revenue: US$370.9m (down 25% from 2Q ...

Baron Capital’s Q2 report highlights biotech, surgical tech, and GLP-1 winners. Discover which health care stocks surged and ...

Apple removed blood oxygen monitoring from the Apple Watch in early 2024. Somebody has to blink for it to return, and it ...

Masimo Corp. (MASI) on Tuesday reported second-quarter profit of $51.3 million. On a per-share basis, the Irvine, California-based company said it ...

Masimo outlines 24–30% EPS growth for 2025 while advancing commercial strategy and tariff mitigation Aug. 05, 2025 11:04 PM ET Masimo Corporation (MASI) Stock AI-Generated Earnings Calls Insights ...